The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity ...

Investors increased their allocations to pharmaceuticals, banks, and industrials in November, according to the latest BofA ...

The S&P 500 rallied in the wake of last week's election results, climbing 3.8% since Nov. 5 at Wednesday's prices. But not ...

Farther Finance Advisors LLC grew its position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report) by 97.1% during the third quarter, HoldingsChannel reports.

The SPDR S&P Pharmaceuticals ETF is seeing unusually high volume in afternoon trading Tuesday, with over 210,000 shares traded versus three month average volume of about 38,000. Shares of XPH were ...

SPDR® S&P Biotech ETF is a well-diversified, low-cost ETF that can be an excellent tool to capitalize on the potential of the biotech stock sector. XBI's performance should be compared with the ...

The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Involves transaction of at least 0.5% of the listed shares of a company. What was Nippon India NIFTY Pharma ETF Growth Plan share price previously? Nippon India NIFTY Pharma ETF Growth Plan share ...

What is the category of Nippon India Nifty Pharma ETF ? The category of Nippon India Nifty Pharma ETF is Equity - Sector - Healthcare What is the current NAV of Nippon India Nifty Pharma ETF ...